Hepatic tumor necrosis factor-α, leptin and adiponectin expression in morbid obese patients: Clinicopathological correlations

被引:0
|
作者
Liew, Phui-Ly [2 ,3 ]
Chen, Chi-Long [4 ]
Lee, Yi-Chih [5 ]
Huang, Ming-Te [6 ]
Wang, Weu [7 ]
Lee, Wei-Jei [1 ]
机构
[1] Min Sheng Gen Hosp, Dept Surg, Taoyuan Hsien, Taiwan
[2] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan
[3] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[4] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan
[5] Ching Yun Univ, Dept Int Business, Jhongli, Taiwan
[6] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan
[7] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan
关键词
Hepatic adipocytokines; Clinicopathology; Morbid obesity; NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; SERUM LEPTIN; STEATOHEPATITIS; DISEASE; FIBROSIS; PATHOGENESIS; RECEPTORS; WEIGHT; NASH;
D O I
10.1016/j.orcp.2011.04.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) is associated with obesity. We retrospectively studied the clinicopathology and different hepatic adipocytokine expressions between nonalcoholic steatohepatitis (NASH) and non-NASH in morbid obesity. Methods: We enrolled 40 patients undergoing liver biopsy during bariatric surgery. We analyzed hepatic mRNA and immunohistochemistry of TNF-alpha, leptin, adiponectin and adiponectin receptor. Results: Thirty patients (75%) presented with NASH, including 11 with mild fibrosis and 19 with advanced fibrosis. The HbA1c (P = 0.000), AST (P = 0.000), ALT (P = 0.000), GGT (P = 0.016) and liver fibrosis (P = 0.028) have statistically difference between NASH and non-NASH groups. Steatosis was the only significant factor (r = 0.348, P < 0.05) associated with TNF-alpha mRNA level. Adiponectin mRNA was inversely associated with C-peptide (r = -0.416, P < 0.05) and uric acid level (r = -0.426, P < 0.05). The best predictors for TNF-alpha immunostain were hemoglobin (r = 0.432, P < 0.01), AST (r = 0.371, P < 0.05), lobular inflammation (r = 0.315, P < 0.05), portal inflammation (r = 0.331, P < 0.05), and NAS (r = 0.365, P < 0.05). Leptin immunostain was correlated with C-peptide (r = 0.356, P < 0.05) and portal inflammation (r = 0.334, P < 0.05). The AdipoRII immunoexpression was negatively correlated with systolic blood pressure (r = -0.481, P < 0.01). Multivariate linear regressions of adipocytokine profile related mostly to age, gender, systolic blood pressure, serum uric acid, steatosis, NAS and portal inflammation. Conclusion: Although different adipocytokines may be associated with NAFLD progression in morbid obesity, their major correlations in the pathogenesis of obesity-related NASH are not clear. Additional confirmatory studies are deserved. (C) 2011 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E55 / E62
页数:8
相关论文
共 50 条
  • [1] COMPARISON OF ADIPOSE TISSUE GENE EXPRESSION OF ADIPONECTIN, TUMOR NECROSIS FACTOR-α AND LEPTIN IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME
    Gormez, S.
    Demirkan, A.
    Caynak, B.
    Atalar, F.
    Gunay, D.
    Akpinar, B.
    Ozbek, U.
    Aytekin, V.
    Yazicioglu, N.
    Buyukdevrim, A. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 20 - 20
  • [2] Adipose Tissue Gene Expression of Adiponectin, Tumor Necrosis Factor-α and Leptin in Metabolic Syndrome Patients with Coronary Artery Disease
    Gormez, Selcuk
    Demirkan, Ayse
    Atalar, Fatmahan
    Caynak, Baris
    Erdim, Refik
    Sozer, Volkan
    Gunay, Demet
    Akpinar, Bellhan
    Ozbek, Ugur
    Buyukdevrim, Ahmet Sevim
    INTERNAL MEDICINE, 2011, 50 (08) : 805 - 810
  • [3] Variations of tumor necrosis factor-α,leptin and adiponectin in mid-trimester of gestational diabetes mellitus
    GAO XuelianYANG Huixia and ZHAO Yi Department of Obstetrics GynecologyPeking University First HospitalBeijing China
    中华医学杂志(英文版), 2008, (08) : 701 - 705
  • [4] Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects
    Corica, F
    Allegra, A
    Corsonello, A
    Buemi, M
    Calapai, G
    Ruello, A
    Mauro, VN
    Ceruso, D
    INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (04) : 355 - 360
  • [5] Serum Leptin, Adiponectin and Tumor Necrosis Factor-α in Hyperlipidemic Rats with/without Concomitant Diabetes Mellitus
    Angeliki Margoni
    Despoina N. Perrea
    Ioannis Vlachos
    Georgia Prokopaki
    Alkistis Pantopoulou
    Lambros Fotis
    Maria Kostaki
    Athanasios G. Papavassiliou
    Molecular Medicine, 2011, 17 : 36 - 40
  • [6] Serum Leptin, Adiponectin and Tumor Necrosis Factor-α in Hyperlipidemic Rats with/without Concomitant Diabetes Mellitus
    Margoni, Angeliki
    Perrea, Despoina N.
    Vlachos, Ioannis
    Prokopaki, Georgia
    Pantopoulou, Alkistis
    Fotis, Lambros
    Kostaki, Maria
    Papavassiliou, Athanasios G.
    MOLECULAR MEDICINE, 2011, 17 (1-2) : 36 - 40
  • [7] Variations of tumor necrosis factor-α, leptin and adiponectin in mid-trimester of gestational diabetes mellitus
    Gao Xue-lian
    Yang Hui-xia
    Zhao Yi
    CHINESE MEDICAL JOURNAL, 2008, 121 (08) : 701 - 705
  • [8] Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects
    F Corica
    A Allegra
    A Corsonello
    M Buemi
    G Calapai
    A Ruello
    V Nicita Mauro
    D Ceruso
    International Journal of Obesity, 1999, 23 : 355 - 360
  • [9] β-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-α expression in adipocytes
    Fu, Ling
    Isobe, Kazumasa
    Zeng, Qin
    Suzukawa, Kazumi
    Takekoshi, Kazuhiro
    Kawakami, Yasushi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 569 (1-2) : 155 - 162
  • [10] Tumor necrosis factor-α in sera of obese patients:: Fall with weight loss
    Dandona, P
    Weinstock, R
    Thusu, K
    Abdel-Rahman, E
    Aljada, A
    Wadden, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08): : 2907 - 2910